Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

NCT03395184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: PF-06651600 Placebo
DRUG: PF-06651600
DRUG: Placebo PF-06700841
DRUG: PF-06700841

Sponsor

Pfizer